Recently published in the Journal of Experimental & Clinical Cancer Research, â€œAntitumor activity of colloidal silver on MCF-7 human breast cancer cellsâ€ is great hope on two fronts: 1) the medical establishment is increasingly starting to tap the benefits of side-effect free colloidal silver, and 2) hard to treat diseases and their expensive, side-effect laden treatments may become things of the past.
Colloidal silver, which is well known for being a natural antibiotic, antiviral, and antifungal agent, as well as for itâ€™s effectiveness in healing wounds like burns, has rarely before been tested for antitumor properties.
An in-vitro test by the researchers Franco-Molina et al. found that the right concentration of colloidal silver for LD100 (meaning all the cancer cells died) was 14ng/mL. The colloidal silver did not kill the PBMC (Peripheral blood mononuclear cells, or, in other words, cells belonging to the immune system).
The researchers concluded that â€œcolloidal silver might be a potential alternative agent for human breast cancer therapyâ€. This is the very beginning of research, only one type of breast cancer having been tested, and it will take years before human testing begins, much less before itâ€™s approved for mass use. However, given the lack of side effects from colloidal silver use, one hopes that the process will be expedited (most drugs are set back when the side effects are shown to outweigh the benefit).
Colloidal silver is frequently criticized as not being â€œsafe or effectiveâ€, numerous studies such as this show that it is probably both, and over the hundreds of years that colloidal silver was used before the discovery of modern antibiotics no negative side effects have been discovered. Argyria is a possible side effect, but is strictly cosmological, and has only been reported with home generators and low-quality colloidal silver knock-offs.
Are you optimistic that this will be a breakthrough in the treatment of cancer?